Group 1 - The Dividend Aristocrats are underperforming compared to the S&P 500, trailing the index in both April and May [1] - As of May 23rd, the ProShares S&P 500 Dividend Aristocrat ETF (NOBL) has increased by 0.84% [1]

Core Insights - Dividend Aristocrats are companies that have increased their dividends for at least 25 consecutive years, demonstrating resilience during economic downturns and showing strength amidst trade-war uncertainties [1] - Medtronic (NYSE: MDT) has been identified as a standout company within the healthcare sector, which is projected to reach $1.87 trillion by 2030 [1][4] Company Analysis - Medtronic operates in over 150 countries with a market capitalization of $103.48 billion, focusing on treatments for cardiovascular disease, diabetes, and neurological disorders [8] - The stock of Medtronic has fluctuated within a 52-week range of $75.96 to $96.25, with analysts projecting an upside of 18.79% and a target price exceeding $109 in the next 12 months [9] - Medtronic has a dividend yield of 3.52% and a payout ratio of 76.98%, indicating strong long-term reinvestment potential [11] Sector Overview - The U.S. healthcare sector is immensely profitable, with demand remaining steady regardless of economic cycles, similar to the grocery and consumer staples sector [4][6] - Pharmaceutical giants, health insurers, and medical device manufacturers are seen as promising investments due to the essential nature of healthcare services [4] Comparative Analysis - Abbott Laboratories (NYSE: ABT) is another Dividend Aristocrat, having raised its dividend for 53 consecutive years and operating in over 160 countries [11] - UnitedHealth Group (NYSE: UNH), the largest health insurance provider in the U.S., has faced challenges but maintains a strong dividend growth rate of 14.60% per year over the past five years [12][13] - AbbVie (NYSE: ABBV) and Becton Dickinson (NYSE: BDX) are also notable companies in the sector, with AbbVie facing competition and pricing rule changes, while Becton Dickinson has seen its stock outlook downgraded amid performance concerns [14][15]

Chevron Corp. NYSE: CVX stock has been surprisingly volatile since it announced earnings on May 2. Supply and demand are under pressure from the current administration’s tariff policies. Plus, like all oil companies, Chevron has been facing oil prices under $60 since OPEC+ announced it was increasing production. The move by OPEC+ underscores the cyclical nature of energy stocks in general and, in particular, oil stocks. It’s also where an opportunity is presenting itself to long-term investors. Chevron Toda ...

Click here for a two-week free trial , so we can help you achieve better long-term total returns and your financial dreams.My family and I are going on a two-week wedding vacation starting next week, so this article has to provide actionable investment ideas for whatever is likely to happen in the short term.He is a founding author of the investing group The Dividend Kings which focuses on helping investors safeguard and grow their money in all market conditions through the highest-quality dividend investme ...

Analyst's Disclosure: I/we have a beneficial long position in the shares of ABBV, JNJ, ROP, HRL, O, LOW, NEE, PEP, TROW, WST either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation ...

Core Insights - NNN REIT is one of the oldest triple net lease REITs in the US, established in 1984, and has maintained 35 years of uninterrupted dividend growth [1] - The company began with a modest portfolio in Florida and has since expanded significantly, becoming a major player in the industry [1] Company Characteristics - NNN REIT focuses on companies that exhibit growth in revenue, earnings, and free cash flow [1] - The company seeks investments with excellent growth prospects and favorable valuations [1] - NNN REIT prefers steadily growing companies with high free cash flow margins, dividend stocks, and those with generous share repurchase programs [1]

Medtronic TodayMDTMedtronic$82.80 +1.00 (+1.22%) 52-Week Range$75.96▼$96.25Dividend Yield3.38%P/E Ratio25.17Price Target$96.14Add to WatchlistInvestors increasingly seek stable and resilient investments in today's volatile and economically uncertain market. Consequently, it is crucial to identify companies with strong fundamentals, defensive strategies, and dependable shareholder returns. Medtronic plc NYSE: MDT, a leading global healthcare technology company, stands out as a compelling option. It offers a ...

Dividend Aristocrats are outperforming so far in 2025. The ProShares S&P 500 Dividend Aristocrats ETF ( NOBL ) is down by just 3.4% year to date, posting more than 6 percentage points of alpha to the S&P 500.Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a narrative to financial data. ...

Realty Income TodayORealty Income$55.14 +0.99 (+1.82%) 52-Week Range$50.65▼$64.88Dividend Yield5.84%P/E Ratio52.51Price Target$62.42Add to WatchlistRealty Income Corporation NYSE: O is a prominent real estate investment trust known for its reliable income stream. The company navigates market pressures while reaffirming its core commitment to shareholders. Realty Income’s depressed share price, combined with its recently increased dividend and status as an S&P 500 Dividend Aristocrat with a history of consi ...